Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-040286
Filing Date
2024-10-07
Accepted
2024-10-07 16:15:21
Documents
6
Period of Report
2024-10-07

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 622939
2 formdef14a_001.jpg GRAPHIC 70020
3 formdef14a_002.jpg GRAPHIC 56354
4 formdef14a_003.jpg GRAPHIC 237725
5 proxycard_001.jpg GRAPHIC 3062168
6 proxycard_002.jpg GRAPHIC 1759345
  Complete submission text file 0001493152-24-040286.txt   7748990
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-11460 | Film No.: 241358027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)